Valeant Pharmaceuticals Intl Inc (VRX) and Allergan, Inc. (AGN)'s Hostile Saga Nears Its End
On 18th December the winner of the epic corporate battle between Allergan, Inc.
Valeant Pharmaceuticals International (VRX)
Market is closed
News
- First
- << Previous
- 211 - 220
- Next >>
Hedge Fund News: Phil Falcone, Louis Hanover & Bridgewater Associates
Minnesota Wild co-owner Phil Falcone might quit his hockey-crazed home state to make a play for the New York Islanders, The Post has learned.
Hedge Fund News: David Harding, Chris Hohn & Valueact Capital
Hedge fund boss gives £5 million to build new museum maths gallery (Standard) A hedge fund manager who built his business on mathematical reasoning has given the Science Museum an unprecedented £5 million...
Allergan, Inc. (AGN) Is Going to Have a Special Shareholders' Meeting
CNBC's David Faber delivered the news that Allergan, Inc. (NYSE:AGN) is going to have a special shareholders' meeting on December 18th.
Hedge Fund News: Bill Ackman, David Einhorn & Aurelius Capital Management
When William Ackman took the stage at the AXA Equitable Auditorium in Midtown Manhattan on April 22, investors were still digesting the news that his firm, Pershing Square Capital Management, had amassed...
Allergan (AGN): Valeant Pharmaceuticals (VRX), Ackman Plan To Request Shareholders Meeting
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Bill Ackman’s Pershing Square Capital Management will today comply with one of Allergan, Inc.
Walgreen Company (WAG), llumina Inc. (ILMN), Valeant Pharmaceuticals Intl Inc (VRX): Billionaire Andreas Halvorsen's Top Stock Picks
Andreas Halvorsen’s Viking Global recently disclosed its long equity positions for the second quarter of 2014. The fund declared holdings worth more than $22.9 billion.
Baidu Inc (ADR) (BIDU), Cognizant Technology Solutions Corp (CTSH), Valeant Pharmaceuticals Intl Inc (VRX): Stephen Mandel’s Top Three Stock Picks
Stephen Mandel’s Lone Pine Capital has revealed for the second quarter a portfolio of 67 companies worth $24.7 billion.
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX), Motorola Solutions Inc (MSI): Jeffrey Ubben’s Top Stock Picks
Jeffrey Ubben’s ValueAct Capital has disclosed its holdings for the second quarter, revealing 16 investments which have a current market value of $13.5 billion.
- First
- << Previous
- 211 - 220
- Next >>
Billionaire Hedge Funds
